-
Plenary Session IV
Professor Jens PahnkeDone
-
Hot Topics II: New biomolecules: Challenges in the development and clinical translation
Carlos Neto, PharmD: Medical Scientific Liaison at Angelini Pharma Portugal and Pedro Madureira, Co-founder and CSO at IMMUNETHEPDone
-
Flash Session III (B)
Andreia MagalhãesDone
-
Congress Dinner
Done
-
Closing Session
Done
-
Coffee Break
Done
-
Flash Session II (A)
Melissa MarianaDone
-
Flash Session II (B)
Ana ValenteDone
-
Flash Session II (C)
Carolina RibeiroDone
-
Oral Session I A
Cristiana MateusDone
Enterprise Plenary Session II
14/02/2023, 17:20
-
14/02/2023, 18:20
(UTC)
(1 hour)
Carlos Neto (PharmD)
Medical Science Liaison - Neuroscience
at Angelini Pharma
carlos.neto@angelinipharma.com
PharmD, 7 + years of experience in the Pharmaceutical Industry, namely in Medical Affairs & Clinical Research, at Janssen, AstraZeneca, and Angelini Pharma. Therapeutic areas: Neuroscience, Cardiometabolism, Oncology, and Immuno-Oncology. Currently works at the Medical Affairs department of Angelini (national launch of new product in Neurology). Experienced researcher with two international experiences (University of Oxford, UK, and University of Bonn, Germany) and past filiation with iMed.UL.